VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 29th, 2021 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Marc Stapley (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of June 1, 2021 (the “Effective Date”).
May 28, 2021 Ms. Bonnie Anderson Delivered by hand or via email Dear Bonnie:Severance Agreement • July 29th, 2021 • Veracyte, Inc. • Services-medical laboratories • California
Veracyte, Inc. (the “Company”) is pleased to offer you this letter agreement (this “Agreement”) setting forth the terms and conditions of your transition to, and employment as, Executive Chairman of the Company.
MEMORANDUM OF UNDERSTANDING by and among Veracyte, Inc. and MI 3 SA SHAM Innovation Santé BNP Paribas Développement Sofipaca FPCI PSIM FIP Amundi France Développement 2015 FIP Amundi France Développement 4 Quest for Growth Philis Vincent Fert Stéphane...Securities Purchase and Contribution Agreement • July 29th, 2021 • Veracyte, Inc. • Services-medical laboratories
(the above Parties from (1) to (8), acting severally but not jointly (conjointement et non solidairement) being hereinafter referred to individually as the Institutional Seller and collectively as the Institutional Sellers)
May 7, 2021 Mr. Marc Stapley Delivered by hand or via email Dear Marc:Confidentiality Agreement • July 29th, 2021 • Veracyte, Inc. • Services-medical laboratories • California
Veracyte, Inc.(the “Company”) is pleased to offer you employment on the terms and conditions set forth in this letter agreement (this “Agreement”).
